XML 34 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 4,577 $ 3,855
Investments 1,371 2,045
Accounts receivable, net 11,719 10,473
Inventories 2,160 2,821
Other current assets 1,341 1,236
Total current assets 21,168 20,430
Long-term investments 28,904 26,929
Reinsurance recoverables 5,274 5,507
Deferred policy acquisition costs 2,795 2,821
Property and equipment 4,448 4,562
Goodwill 44,462 44,505
Other intangible assets 37,084 39,003
Other assets 2,379 1,630
Separate account assets 8,333 7,839
TOTAL ASSETS 154,847 153,226
Liabilities:    
Current insurance and contractholder liabilities 7,180 6,801
Pharmacy and service costs payable 10,857 10,702
Accounts payable 4,502 4,366
Accrued expenses and other liabilities 7,196 7,071
Short-term debt 4,712 2,955
Total current liabilities 34,447 31,895
Non-current insurance and contractholder liabilities 20,090 19,974
Deferred tax liabilities, net 9,284 9,453
Other non-current liabilities 3,919 3,470
Long-term debt 34,041 39,523
Separate account liabilities 8,333 7,839
TOTAL LIABILITIES 110,114 112,154
Redeemable noncontrolling interests 34 37
Shareholders' Equity    
Common stock 4 4
Additional paid-in capital 28,115 27,751
Accumulated other comprehensive income (loss) (858) (1,711)
Retained earnings 19,185 15,088
Less: treasury stock, at cost (1,750) (104)
TOTAL SHAREHOLDERS' EQUITY 44,696 41,028
Other noncontrolling interests 3 7
Total equity 44,699 41,035
Total liabilities and shareholders' equity $ 154,847 $ 153,226
Shareholders' Equity Per Share $ 119.52 $ 107.71